TLC to Present at the 42nd Annual JP Morgan Healthcare Conference
December 27, 2023 05:40 ET
|
TLC
TLC BioSciences to Present at 42nd Annual JP Morgan Healthcare Conference in San Francisco
Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts Session
November 20, 2023 03:54 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter, Florance and Cope Chair of Rheumatology at the University of Sydney, presented detailed...
TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR
November 08, 2023 04:54 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC Announces TLC599 Agreement with Endo
June 13, 2022 06:30 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target...
TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy
March 07, 2022 04:57 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 07, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas...
TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares
September 08, 2021 04:41 ET
|
TLC
This communication does not constitute an offer of any securities for sale or subscription or a solicitation of an offer to purchase or subscribe to any securities in any jurisdiction. The securities...
TLC Reports Second Quarter 2021 Financial Results and Provides Business Update
August 12, 2021 05:44 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 12, 2021 (GLOBE NEWSWIRE) -- TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet...
TLC Announces Details of Stock Swap Transactions
July 05, 2021 06:16 ET
|
TLC
TAIPEI, Taiwan, July 05, 2021 (GLOBE NEWSWIRE) -- Taiwan Liposome Company (Nasdaq: TLC, TWO: 4152, “the company”), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India
May 26, 2021 04:30 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 26, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India
May 25, 2021 05:05 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 25, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...